BackOrchestra BioMed Holdings Overview
Orchestra BioMed Holdings Inc

Orchestra BioMed Holdings Target Price

See Orchestra BioMed Holdings's analyst price targets ($10) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.95

Average Target Price

$10.0068.1% upside

2 analysts in the last 4 months

High: $10 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-10BTIGMarie Thibault$1068.1% upsideOpen
2026-08-11Piper SandlerMatt O'Brien$1068.1% upsideOpen
2026-05-13BarclaysMatt Miksic$13118.5% upsideOpen
2026-01-09BarclaysMatt Miksic$12101.7% upsideOpen
2025-03-20BTIGMarie Thibault$12101.7% upsideOpen

Orchestra BioMed Holdings (OBIO) FAQ

The latest target price for OBIO is $10. Investors often review this figure alongside Orchestra BioMed Holdings's historical trend and sector peers before judging valuation or financial health.

Orchestra BioMed Holdings trades near $5.95 while the consensus target sits at $10 (68.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting OBIO's target price ($10), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.